Learning Objectives:

1.  Provide an overview of factors which may impact immunotherapeutic approaches for GBM.

2.  Discuss the role of IDO in creating an immunosuppressive tumor microenvironment in GBM.

3.  Highlight the use of cytokines to create an immunologically "hot" environment in GBM.

Session date: 
06/21/2022 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Rimas Lukas, MD